The saying goes, “you pays your money and you makes your choice.” In 2012, if you have a bolus of $20,700 to spend, you can choose between a health plan for a family of four, or a sedan for the same family. That’s the calculation from the actuaries at Milliman, whose annual Milliman Medical Index [...]
Archive | Pharmacy RSS feed for this section
Improving health care through Big Data: a meeting of the minds at SAS
Some 500 data analytics gurus representing the health care ecosystem including hospitals, physician practices, life science companies, academia and consulting came together on the lush campus of SAS in Cary, North Carolina, this week to discuss how Big Data could solve health care’s Triple Aim, as coined by keynote speaker Dr. Donald Berwick: improve the [...]
It’s the prices and the technology, stupid: why U.S. health costs are higher than anywhere in the world
The price of physician services, proliferation of clinical technology and the cost of obesity are the key drivers of higher health spending in the U.S., according to The Commonwealth Fund‘s latest analysis in their Issues of International Health Policy titled, Explaining High Health Care Spending in the United States: An International Comparison of Supply, Utilization, [...]
Americans continue to self-ration health care in the economic recovery
Even though Inside-the-Beltway economists have said The Great Recession of 2007 is officially over, it doesn’t look that way when you ask consumers about health spending in 2012, based on results from a survey conducted on behalf of the American Osteopathic Association (AOA). One in 5 U.S. adults is trying to lower their personal health spending. [...]
What the FDA needs to know about Rx health consumers: most Americans see value in pharma-sponsored health social networks
In PwC‘s landmark report, Social Media “Likes” Healthcare, there’s a data point obscured by lots of great information generated by the firm’s survey of 1,060 U.S. adults: that over one-half of people value patient support groups and social networks with other patients that are offered by drug companies. Not surprisingly, U.S. consumers. who are taking on [...]
About Jane & Health Populi
Jane Sarasohn-Kahn is a health economist and management consultant that serves clients at the intersection of health and technology.
Her clients include all stakeholders in health, including providers, payors and plans; companies in biopharma, medical devices, financial services, technology and consumer goods; non-profits and NGOs. Jane's lens on health is best-defined by the World Health Organization: health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.
-
ePatients: a connected, collaborative, creating community
-
Patients want online communication with doctors, and more clinicians are listening
-
Meeker & Murphy on Mobile – through the lens of health
-
Patient Power Through Data Liberación, and Private Sector to the Rescue – Health 2.0 DC Takeaways
